Join the 155,000+ IMP followers

Nvidia News

Life sciences adopt NVIDIA BioNeMo for AI drug discovery

NVIDIA’s BioNeMo platform is being adopted by pharmaceutical companies and research organizations to integrate AI models, laboratory data and automation for scalable, data-driven drug discovery.

Join the 155,000+ IMP followers